2014. Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment . Brazilian Journal of Pharmaceutical Sciences. 50, 2 (Apr. 2014), 345–352. DOI:https://doi.org/10.1590/S1984-82502014000200014.